辅助药物-话题@MedSci

#辅助药物#

6篇内容 | 290人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1813784, encodeId=f9bc1813e849c, content=<a href='/topic/show?id=7f0193e09a7' target=_blank style='color:#2F92EE;'>#辅助药物#</a>, objectTitle=Nat Med：新辅助药物纳武单抗单药治疗或联合伊匹单抗治疗可进行手术的非小细胞肺癌患者的临床研究, objectType=article, longId=207391, objectId=875f20e391ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=875f20e391ec, replyNumber=0, likeNumber=55, createdTime=2021-09-04, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=875f20e391ec, moduleTitle=Nat Med：新辅助药物纳武单抗单药治疗或联合伊匹单抗治疗可进行手术的非小细胞肺癌患者的临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=875f20e391ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813783, encodeId=c6541813e832d, content=<a href='/topic/show?id=7f0193e09a7' target=_blank style='color:#2F92EE;'>#辅助药物#</a>, objectTitle=Lancet oncol：新辅助药物达拉非尼联合曲美替尼疗法用于III期黑色素瘤的疗效评估, objectType=article, longId=167652, objectId=245216e65298, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=245216e65298, replyNumber=0, likeNumber=46, createdTime=2019-10-21, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=245216e65298, moduleTitle=Lancet oncol：新辅助药物达拉非尼联合曲美替尼疗法用于III期黑色素瘤的疗效评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=245216e65298)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813781, encodeId=50681813e8168, content=<a href='/topic/show?id=7f0193e09a7' target=_blank style='color:#2F92EE;'>#辅助药物#</a>, objectTitle=J Clin Periodontol：阿莫西林加甲硝唑作为非外科牙周治疗辅助药物的更佳剂量和持续时间分析, objectType=article, longId=128097, objectId=191312809eb8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=191312809eb8, replyNumber=0, likeNumber=40, createdTime=2018-05-11, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=191312809eb8, moduleTitle=J Clin Periodontol：阿莫西林加甲硝唑作为非外科牙周治疗辅助药物的更佳剂量和持续时间分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=191312809eb8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813782, encodeId=28c61813e8271, content=<a href='/topic/show?id=7f0193e09a7' target=_blank style='color:#2F92EE;'>#辅助药物#</a>, objectTitle=SCI REP：非胰岛素降糖药作为2型糖尿病患者胰岛素治疗辅助药物的比较！, objectType=article, longId=131697, objectId=ff7313169e9a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff7313169e9a, replyNumber=0, likeNumber=48, createdTime=2018-04-13, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff7313169e9a, moduleTitle=SCI REP：非胰岛素降糖药作为2型糖尿病患者胰岛素治疗辅助药物的比较！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff7313169e9a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813780, encodeId=33e21813e8057, content=<a href='/topic/show?id=7f0193e09a7' target=_blank style='color:#2F92EE;'>#辅助药物#</a>, objectTitle=Drug Safety：患者和医师对睡眠辅助药物安全信息的认知, objectType=article, longId=106193, objectId=a148106193df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a148106193df, replyNumber=0, likeNumber=31, createdTime=2017-08-07, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a148106193df, moduleTitle=Drug Safety：患者和医师对睡眠辅助药物安全信息的认知, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a148106193df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1813779, encodeId=87fc1813e7992, content=<a href='/topic/show?id=7f0193e09a7' target=_blank style='color:#2F92EE;'>#辅助药物#</a>, objectTitle=肿瘤化疗辅助药物研究进展, objectType=article, longId=2024, objectId=6a9720244f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6a9720244f, replyNumber=0, likeNumber=32, createdTime=2011-02-20, rootId=0, userName=bluefate121, userId=93e223, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6a9720244f, moduleTitle=肿瘤化疗辅助药物研究进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6a9720244f)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

辅助药物

2020-05-29

bluefate121 (审核中...)

前往app查看评论内容

#辅助药物#

Nat Med：新辅助药物纳武单抗单药治疗或联合伊匹单抗治疗可进行手术的非小细胞肺癌患者的临床研究

2021-09-04

bluefate121 (审核中...)

前往app查看评论内容

#辅助药物#

Lancet oncol：新辅助药物达拉非尼联合曲美替尼疗法用于III期黑色素瘤的疗效评估

2019-10-21

仁者大医 (审核中...)

前往app查看评论内容

#辅助药物#

J Clin Periodontol：阿莫西林加甲硝唑作为非外科牙周治疗辅助药物的更佳剂量和持续时间分析

2018-05-11

bluefate121 (审核中...)

前往app查看评论内容

#辅助药物#

SCI REP：非胰岛素降糖药作为2型糖尿病患者胰岛素治疗辅助药物的比较！

2018-04-13

bluefate121 (审核中...)

前往app查看评论内容

#辅助药物#

Drug Safety：患者和医师对睡眠辅助药物安全信息的认知

2017-08-07

bluefate121 (审核中...)

前往app查看评论内容

#辅助药物#

肿瘤化疗辅助药物研究进展

2011-02-20

科室
- - 订阅+
  - 更多科室
工具
服务